Phase 3 trials for amycretin are expected to begin enrolling by late 2025 or early 2026
We empower you to achieve significant, lasting results with compassionate, professional care
Are there any specific foods or drinks I should avoid
development of safer modulators, such as next-generation inflammasome inhibitors targeted to activated immune cells via antibodies to activation markers, or ROS-activated prodrugs and nanoparticles to ensure localized action
A clinical trial at Northwestern University (NCT07207148) is currently investigating GLP-1 agonists specifically in MS patients, and results from randomised trials will be needed to establish whether these medications have genuine disease-modifying effects
They are trained to evaluate the underlying causes of pain, whether its related to medication, an existing medical condition, or another factor